People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| A-Alpha Bio, Inc. | — | Biotech / Pharma | Series B | $23.1M | $464.7M | 2019 |
David Younger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Younger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matt McIlwain | 1 | 25 |
| Ben Askew | 1 | 3 |
| Randolph Lopez Barrezueta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.